This risk concerns new, aggressive investment aimed at developing value-added products, which may carry higher potential risks than conventional investment. It addresses risks inherent in value-added product investment itself, rather than being limited to specific impacts such as delayed investment recovery, lower short-term profit margins, or failed product development.